Le Cesne A - Search Results

1

Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors.

Dufresne A, Pissaloux D, Ngo C, Penel N, Le Cesne A, Macagno N, Vanacker H, Hénon C, Jean-Denis M, Rughoo K, Tirode F, Blay JY, Brahmi M. Dufresne A, et al. Among authors: le cesne a. ESMO Open. 2023 Apr;8(2):101202. doi: 10.1016/j.esmoop.2023.101202. Epub 2023 Apr 11. ESMO Open. 2023. PMID: 37054503 Free PMC article.

2

Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.

Blay JY, Chauvin F, Le Cesne A, Anglaret B, Bouhour D, Lasset C, Freyer G, Philip T, Biron P. Blay JY, et al. Among authors: le cesne a. J Clin Oncol. 1996 Feb;14(2):636-43. doi: 10.1200/JCO.1996.14.2.636. J Clin Oncol. 1996. PMID: 8636781

3

A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy.

Blay JY, Le Cesne A, Mermet C, Maugard C, Ravaud A, Chevreau C, Sebban C, Guastalla J, Biron P, Ray-Coquard I. Blay JY, et al. Among authors: le cesne a. Blood. 1998 Jul 15;92(2):405-10. Blood. 1998. PMID: 9657738 Free article.

4

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients.

Fizazi K, Dohollou N, Blay JY, Guérin S, Le Cesne A, André F, Pouillart P, Tursz T, Nguyen BB. Fizazi K, et al. Among authors: le cesne a. J Clin Oncol. 1998 Dec;16(12):3736-43. doi: 10.1200/JCO.1998.16.12.3736. J Clin Oncol. 1998. PMID: 9850016

5

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.

Ray-Coquard I, Le Cesne A, Rubio MT, Mermet J, Maugard C, Ravaud A, Chevreau C, Sebban C, Bachelot T, Biron P, Blay JY. Ray-Coquard I, et al. Among authors: le cesne a. J Clin Oncol. 1999 Sep;17(9):2840-6. doi: 10.1200/JCO.1999.17.9.2840. J Clin Oncol. 1999. PMID: 10561360

6

Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.

Le Cesne A, Judson I, Crowther D, Rodenhuis S, Keizer HJ, Van Hoesel Q, Blay JY, Frisch J, Van Glabbeke M, Hermans C, Van Oosterom A, Tursz T, Verweij J. Le Cesne A, et al. J Clin Oncol. 2000 Jul;18(14):2676-84. doi: 10.1200/JCO.2000.18.14.2676. J Clin Oncol. 2000. PMID: 10894866 Clinical Trial.

7

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.

Ray-Coquard I, Ghesquière H, Bachelot T, Borg C, Biron P, Sebban C, LeCesne A, Chauvin F, Blay JY; ELYPSE Study Group. Ray-Coquard I, et al. Br J Cancer. 2001 Sep 14;85(6):816-22. doi: 10.1054/bjoc.2001.2011. Br J Cancer. 2001. PMID: 11556830 Free PMC article.

8

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy.

Blay JY, van Glabbeke M, Verweij J, van Oosterom AT, Le Cesne A, Oosterhuis JW, Judson I, Nielsen OS. Blay JY, et al. Among authors: le cesne a. Eur J Cancer. 2003 Jan;39(1):64-9. doi: 10.1016/s0959-8049(02)00480-x. Eur J Cancer. 2003. PMID: 12504660

9

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy.

Ray-Coquard I, Borg C, Bachelot T, Sebban C, Philip I, Clapisson G, Le Cesne A, Biron P, Chauvin F, Blay JY; ELYPSE study group. Ray-Coquard I, et al. Among authors: le cesne a. Br J Cancer. 2003 Jan 27;88(2):181-6. doi: 10.1038/sj.bjc.6600724. Br J Cancer. 2003. PMID: 12610500 Free PMC article.

10

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.

Le Cesne A, Blay JY, Judson I, Van Oosterom A, Verweij J, Radford J, Lorigan P, Rodenhuis S, Ray-Coquard I, Bonvalot S, Collin F, Jimeno J, Di Paola E, Van Glabbeke M, Nielsen OS. Le Cesne A, et al. J Clin Oncol. 2005 Jan 20;23(3):576-84. doi: 10.1200/JCO.2005.01.180. J Clin Oncol. 2005. PMID: 15659504 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters